These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2907639)

  • 1. Recording automatic and controlled information processing by means of bioelectrical brain signals in normals and paranoid schizophrenics with and without neuroleptic medication.
    Krieger S; Bertling R; Schweizer A; Tegeler J
    Pharmacopsychiatry; 1988 Nov; 21(6):331-3. PubMed ID: 2907639
    [No Abstract]   [Full Text] [Related]  

  • 2. Paranoid schizophrenics may not use irrelevant signals. The use of measures of blocking and of urinary dopamine.
    Oades RD; Bunk D; Eggers C
    Acta Paedopsychiatr; 1992; 55(3):183-4. PubMed ID: 1357915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [EEG performance spectral mapping during drug therapy in a patient with schizophrenic psychosis].
    Schellenberg R; Schwarz A; Knorr W; Schindler M
    Psychiatr Neurol Med Psychol (Leipz); 1990 Oct; 42(10):618-24. PubMed ID: 1981811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
    Tanii H; Fujita K; Okazaki Y
    Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
    [No Abstract]   [Full Text] [Related]  

  • 5. Tardive tourettism after exposure to neuroleptic therapy.
    Bharucha KJ; Sethi KD
    Mov Disord; 1995 Nov; 10(6):791-3. PubMed ID: 8749999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroleptic malignant syndrome--a case report].
    Lanczik M; Fritze J
    Psychiatr Prax; 1992 May; 19(3):84-6. PubMed ID: 1353269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [EEG records and effects of phenothiazine treatment in patients with paranoid schizophrenia].
    Ekiert H; Gogol Z; Welbel L; Kazubska M
    Psychiatr Pol; 1977; 11(3):325-33. PubMed ID: 19798
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose diazepam in neuroleptic-resistant schizophrenia with tardive dyskinesia.
    Eapen V; Mukherjee D; Chandra P; Sinha V; Khanna S; Channabasavanna SM
    J Clin Psychiatry; 1989 Aug; 50(8):309. PubMed ID: 2569459
    [No Abstract]   [Full Text] [Related]  

  • 9. [Peri-/myocarditis with clozapine (Leponex)].
    Khalil N
    Psychiatr Prax; 1997 Jan; 24(1):46. PubMed ID: 9132787
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of antipsychotic medication on pain perception in schizophrenia.
    Jochum T; Letzsch A; Greiner W; Wagner G; Sauer H; Bär KJ
    Psychiatry Res; 2006 Jun; 142(2-3):151-6. PubMed ID: 16631931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Natural evolution of paranoid schizophrenia treated consecutively with 4 different neuroleptics].
    Portier A; Sarfati Y
    Encephale; 2000; 26(4):75-7. PubMed ID: 11064844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].
    Wetzel H; von Bardeleben U; Holsboer F; Benkert O
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():23-9. PubMed ID: 1683336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neuroleptic treatments on attention, information processing, and thought disorder.
    Spohn HE; Coyne L; Mittleman F; Larson J; Johnston M; Spray J; Hayes K
    Psychopharmacol Bull; 1985; 21(3):582-7. PubMed ID: 2863849
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of methadone plus neuroleptics on treatment-resistant chronic paranoid schizophrenia.
    Brizer DA; Hartman N; Sweeney J; Millman RB
    Am J Psychiatry; 1985 Sep; 142(9):1106-7. PubMed ID: 2862800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Remission of schizophrenic psychosis with negative symptoms with risperidone].
    Lübbe R
    Fortschr Med; 1996 Feb; 114(6):35-6. PubMed ID: 8900527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinsonism with intramuscular ziprasidone.
    Bilal L; Tsai C; Gasper JJ; Ndlela JC
    Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in semantic information processing in schizophrenics.
    Volz HP; Mackert A; Frick K; Bücker U
    Pharmacopsychiatry; 1994 Mar; 27(2):59-62. PubMed ID: 7913235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroencephalography in schizophrenic patients: comparison between neuroleptic-naive state and after treatment.
    Nagase Y; Okubo Y; Toru M
    Biol Psychiatry; 1996 Sep; 40(6):452-6. PubMed ID: 8879464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziprasidone-induced acute dystonia.
    Mason MN; Johnson CE; Piasecki M
    Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of malignant neuroleptic syndrome with rhabdomyolysis and a therapeutic trial using physostigmine].
    Krull F; Risse A
    Fortschr Neurol Psychiatr; 1986 Dec; 54(12):398-401. PubMed ID: 2880787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.